Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and commercializes novel therapeutics to treat patients with disorders linked to dysfunctional signaling of the transforming growth factor-beta family of protein...
Q2 2026
Aug 5, 2026
Q1 2026
May 14, 2026
FY 2025
Mar 4, 2026
Q4 2025
Q3 2025
Nov 5, 2025
